Clinical Trial

Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 2, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06535334
Lead Sponsor Far Eastern Memorial Hospital
Conditions Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Enrollment 80 participants
Start Date 2024-08-15
Primary Completion 2025-06 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2024-08-02